Silverberg Daniel, Menes Tehillah, Rimon Uri, Salomon Ophira, Halak Moshe
Department of Vascular Surgery, The Chaim Sheba Medical Center, Tel Hashomer, Israel.
Department of Surgery, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv, Israel.
J Vasc Surg. 2016 Oct;64(4):1026-32. doi: 10.1016/j.jvs.2016.04.043. Epub 2016 Jun 23.
Acute renal artery occlusion is an uncommon disease requiring rapid diagnosis for prevention of kidney loss or permanent kidney damage. The purpose of this study was to identify patients with acute kidney infarction; to characterize their presentation, imaging, and treatment; and to compare the subgroup of patients who underwent catheter-directed thrombolysis (CDT) with those who were treated without intervention.
Hospital records between 2005 and 2015 were queried for keywords suggestive of kidney infarction. Patients were divided into two groups: the CDT group and the noninterventional group. Data collected included demographics, comorbidities, methods of diagnosis, and time from presentation to diagnosis. For patients treated with CDT, additional data collected included details of thrombolytic therapy and follow-up studies. The two groups were compared regarding their clinical characteristics and outcome.
Forty-two patients were diagnosed with acute kidney infarction; 13 (31%) were treated with CDT and 29 (69%) were treated conservatively. Median time from presentation to diagnosis was 42 hours in the CDT group and 32 hours in the untreated group. Among the CDT group, complete or partial resolution of the thrombus was seen in all patients. Two required permanent dialysis, both renal transplant patients. Median follow-up was 30 months (interquartile range, 2.7-46.2) in the CDT group and 13 months (interquartile range, 0.11-16) in the noninterventional group. Mean creatinine clearance at diagnosis and at last follow-up was 74.3 and 54.6 mL/min, respectively, in the CDT group (a decrease of 27%; P = .032) and 66.1 and 60 mL/min in the conservatively treated group (a decrease of 9%; P = .04). Follow-up imaging was available in nine patients treated with CDT. Mean interval from treatment to follow-up imaging was 13 months (range, 1-35 months) and consistently showed a functional but smaller treated kidney. (Mean pole-to-pole kidney length at baseline and late follow-up: 10.4 cm and 8.5 cm, respectively).
Most patients presenting with acute kidney infarction are managed conservatively. A subset of patients with complete occlusion of the renal artery undergo CDT with good angiographic results. The treated kidney is expected to decrease in size over time, and overall kidney function is expected to decrease compared with baseline. Deterioration in renal function appears to stabilize and does not continue over time. CDT for acute renal artery occlusion is a safe modality of therapy and should be attempted for the purpose of kidney salvage, even in the setting of prolonged ischemia.
急性肾动脉闭塞是一种罕见疾病,需要快速诊断以预防肾脏丧失或永久性肾损伤。本研究的目的是识别急性肾梗死患者;描述其临床表现、影像学表现及治疗方法;并比较接受导管定向溶栓(CDT)治疗的患者亚组与未接受干预治疗的患者。
查询2005年至2015年医院记录中提示肾梗死的关键词。患者分为两组:CDT组和非干预组。收集的数据包括人口统计学资料、合并症、诊断方法以及从就诊到诊断的时间。对于接受CDT治疗的患者,收集的其他数据包括溶栓治疗细节和随访研究。比较两组的临床特征和结局。
42例患者被诊断为急性肾梗死;13例(31%)接受CDT治疗,29例(69%)接受保守治疗。CDT组从就诊到诊断的中位时间为42小时,未治疗组为32小时。在CDT组中,所有患者的血栓均完全或部分溶解。2例需要长期透析,均为肾移植患者。CDT组的中位随访时间为30个月(四分位间距,2.7 - 46.2),非干预组为13个月(四分位间距,0.11 - 16)。CDT组诊断时和末次随访时的平均肌酐清除率分别为74.3和54.6 mL/min(下降27%;P = 0.032),保守治疗组分别为66.1和60 mL/min(下降9%;P = 0.04)。9例接受CDT治疗的患者有随访影像学资料。从治疗到随访影像学检查的平均间隔时间为13个月(范围,1 - 35个月),始终显示治疗后的肾脏功能正常但体积较小。(基线和晚期随访时肾脏两极间的平均长度分别为:10.4 cm和8.5 cm)。
大多数急性肾梗死患者接受保守治疗。一部分肾动脉完全闭塞的患者接受CDT治疗,血管造影结果良好。预计治疗后的肾脏体积会随时间减小,与基线相比总体肾功能会下降。肾功能恶化似乎会稳定下来,不会随时间持续进展。急性肾动脉闭塞的CDT是一种安全的治疗方式,即使在存在长时间缺血的情况下,也应尝试用于挽救肾脏。